Venus Concept Announces FDA 510(k) Clearance for Venus Viva MD

July 2, 2020

Venus Concept Inc., a global medical aesthetic technology leader, has announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD, a non-invasive device intended to be used by aesthetic-related physicians or dermatologists. It expands the company’s skin rejuvenation offerings beyond the Venus Viva and Venus Versa, which were introduced to the medical aesthetics market in 2015 and 2016, respectively.
Read more at Globe Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
    • CBS News Investigation Raises Concerns About Unapproved Retatrutide Sales
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform